Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update on JIML

5 May 2026 07:00

RNS Number : 9084C
Jarvis Securities plc
05 May 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update on JIML

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, (the "Transaction"). In order to deliver optimal value for shareholders, the Company has engaged S&W Partners LLP to explore the possibility of a sale of JIML. (the "Potential Disposal"). The Potential Disposal will be subject to conditions set out below and there can be no certainty as to the timing of the Potential Disposal or that it will occur at all.

After the Transaction, the termination of the Model B clearing and settlement services and the wind down of the associated operations (as further detailed in the Announcement) the assets presently remaining in JIML (which has permissions to undertake regulated activities and hold client assets) are:

i. approximately 1,800 clients with assets under administration of circa £44 million (including circa £7 million of potentially illiquid and/or non-returnable client assets), although this is declining as assets are withdrawn;

ii. the right to receive any deferred consideration due from the Transaction;

iii. any remaining cash balances; and 

iv. the group's intellectual property (which includes the "X-O" and "Sharedeal Active" trademarks).

 

It should be noted that any proposed sale of JIML's shares and any associated change of control would be subject to, the FCA's consent. 

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis - C/O S&W Partners LLP - 0204 617 55 00 (Phil Hemming (Phil.hemming@swgroup.com) / Christopher Samson (Samson.christopher@swgroup.com))

 Zeus Capital (Nominated Adviser) - 020 3829 5000 (Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAKQBDFBKDAPK
Date   Source Headline
31st Jul 20099:37 amRNSDirector's Dealings
29th Jul 20097:00 amRNSContract Win
28th Jul 200910:31 amRNSDividend Declaration - Record Date Amendment
28th Jul 20097:00 amRNSInterim Report - six months to 30 June 2009
10th Jun 200912:51 pmRNSDirector/PDMR Shareholding
10th Jun 20097:00 amRNSContract Win
29th May 200912:37 pmRNSDirector/PDMR Shareholding
20th May 20093:24 pmRNSDirector/PDMR Shareholding
18th May 20092:47 pmRNSDirector/PDMR Shareholding
14th Apr 200910:16 amRNSResult of General Meeting
14th Apr 20097:00 amRNSAGM Statement
1st Apr 20097:00 amRNSDirector/PDMR Shareholding
23rd Mar 20092:16 pmRNSAnnual Report and Accounts
4th Mar 20097:01 amRNSInterim Results, AGM Notice & Prior Distributions
4th Mar 20097:00 amRNSFinal Results
20th Feb 20097:00 amRNSContract Wins and Notice of Results
19th Dec 200812:15 pmRNSBoard Changes
17th Dec 20087:00 amRNSTrading Update
15th Oct 200812:18 pmRNSGeneral Meeting Result
15th Oct 200810:48 amRNSGeneral Meeting Statement
25th Sep 200810:00 amRNSChange of Nominated Adviser and Broker
30th Jul 200812:43 pmRNSResult of EGM
29th Jul 20087:00 amRNSInterim Report for the 6 mont
24th Jul 200812:31 pmRNSContract Win / Date of Interi
2nd Jul 20088:46 amRNSHolding(s) in Company/Directo
1st Jul 200812:11 pmRNSTransaction in Own Shares
24th Jun 20084:18 pmRNSTransaction in Own Shares
20th Jun 20089:46 amRNSNotice of EGM
12th Jun 200810:15 amRNSDirector/PDMR Shareholding
22nd May 20083:19 pmRNSRule 8.3- Jarvis Securities p
21st May 200812:38 pmRNSHolding(s) in Company
13th May 20086:00 amRNSStatement re Possible Offer
18th Apr 20087:00 amRNSContract Win
4th Apr 20087:01 amRNSTrading Update/Contract Wins
25th Mar 200812:54 pmRNSTransaction in Own Shares
17th Mar 20081:23 pmRNSTransaction in Own Shares
11th Mar 200812:07 pmRNSContract Win
10th Mar 200812:43 pmRNSTransaction in Own Shares
4th Mar 200811:21 amRNSDirector/PDMR Shareholding
22nd Feb 20084:11 pmRNSOwn Shares/Registered Office
7th Feb 20089:41 amRNSBoard Change/Director Dealing
29th Jan 20081:57 pmRNSPosting of Results
29th Jan 20081:19 pmRNSDirector/PDMR Shareholding
29th Jan 20087:01 amRNSResults to 31 December 2007
18th Jan 200812:00 pmRNSNotice of Results
9th Jan 200810:04 amRNSTransaction in Own Shares
26th Nov 20072:29 pmRNSTransaction in Own Shares
13th Nov 200710:31 amRNSTrading Statement
1st Oct 20071:19 pmRNSTransaction in Own Shares
24th Sep 200711:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.